CTOs on the Move

Hycor Biomedical Inc.

www.hycorbiomedical.com

 
Hycor Biomedical Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Hycor Biomedical Inc. raised $10M on 04/11/2022

Similar Companies

Nexus Communications

Nexus Communications is a North Wales, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Anthem Incorporated

At Anthem, Inc., we believe that our health connects us all. So we focus on being a valued health partner and delivering quality products and services that give members access to the care they need. With more than 67 million people served by our affiliated companies including approximately 37 million enrolled in our family of health plans, we can make a real difference to meet the needs of our diverse customers.

Symbion Research International

Symbion Research International, Inc is a Newbury Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CORHIO

CORHIO is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Denver, CO. To find more information about CORHIO, please visit www.corhio.org

Baxalta

Newly combined with Baxalta, Shire is now the leading global biotechnology company focused on serving people affected by rare diseases and highly specialized conditions. These diseases are often misunderstood, under-diagnosed, and potentially life-threatening. Our 22,000 employees come to work every day with a common purpose: to develop and deliver breakthrough therapies that enable people with life-altering conditions to live their lives to the fullest. At Shire, we are dedicated to expanding, building and sustaining leadership across our key therapeutic areas through our extensive portfolio of products, innovative pipeline and collaborative approach to working with diverse partners around the globe. We strive to earn and keep the trust of our patients, their families and physicians, and all others who support and advance their care. Working together, the possibilities for our patients, healthcare partners and employees are unprecedented, with significant growth potential for our shareholders.